Literature DB >> 36002591

Early marker of ocular neurodegeneration in children and adolescents with type 1 diabetes: the contributing role of polymorphisms in mir146a and mir128a genes.

Claudia Piona1, Silvia Costantini1, Chiara Zusi1, Tiziano Cozzini2, Emilio Pedrotti2, Marco Marigliano1, Elena Fornari1, Alice Maguolo1, Anita Morandi3, Claudio Maffeis1.   

Abstract

BACKGROUND: Early ocular neurodegenerative signs of diabetic neuropathy (DN) can be found in children and adolescents with type 1 diabetes (T1D). No data are available on the potential role of polymorphisms in miRNAs genes in predisposing T1D subjects to these signs. AIMS: To determine whether MIR146A rs2910164 and MIR128A rs11888095 polymorphisms are associated with early retinal and corneal neurodegenerative changes in pediatric patients with T1D.
METHODS: A total of 140 T1D children/adolescents underwent spectral domain-optical coherence tomography (SD-OCT) and in vivo confocal microscopy (IVCM) with measurement of retinal and corneal nerve fiber parameters. Risk factors for diabetes complications (diabetes duration, blood pressure, HbA1c) were recorded. Genotyping of rs2910164 and rs1188095 SNPs and genotype-phenotype association analysis were performed.
RESULTS: The C allele of rs2910164 in MIR146A was associated with higher values of IVCM parameters and minimum rim width (MRW) of the peripapillary region of optic nerve head measured in the retina, whereas the T allele of rs1188095 in MIR128A was associated with a significant impairment of them. Multiple regression analysis showed that MIR146A and MIR128A polymorphisms were significantly associated with corneal nerve fiber length (beta = 0.225 and - 0.204, respectively) and other IVCM parameters, independently from age, diabetes duration, HbA1c and systolic blood pressure percentile. Similar results were found for MRW (beta = 0.213 and - 0.286, respectively).
CONCLUSIONS: These results provide new insight into the genetic predisposition to DN showing that two polymorphisms in MIR146A and MIR128A genes could significantly contribute to the development of early ocular preclinical signs of DN.
© 2022. The Author(s).

Entities:  

Keywords:  Diabetic neuropathy; Genetic susceptibility,; MIR128A gene polymorphism; MIR146A gene polymorphism; MicroRNAs; Ocular neurodegeneration; Type 1 diabetes

Mesh:

Substances:

Year:  2022        PMID: 36002591      PMCID: PMC9581843          DOI: 10.1007/s00592-022-01919-7

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.087


  21 in total

1.  Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes.

Authors:  Cinzia Ciccacci; Roberto Morganti; Davide Di Fusco; Cinzia D'Amato; Laura Cacciotti; Carla Greco; Sara Rufini; Giuseppe Novelli; Federica Sangiuolo; Girolama A Marfia; Paola Borgiani; Vincenza Spallone
Journal:  Acta Diabetol       Date:  2014-03-30       Impact factor: 4.280

2.  Reliability of anthropometric measurements in the WHO Multicentre Growth Reference Study.

Authors: 
Journal:  Acta Paediatr Suppl       Date:  2006-04

Review 3.  Polymorphisms in miRNA genes and their involvement in autoimmune diseases susceptibility.

Authors:  Andrea Latini; Cinzia Ciccacci; Giuseppe Novelli; Paola Borgiani
Journal:  Immunol Res       Date:  2017-08       Impact factor: 2.829

4.  ISPAD Clinical Practice Consensus Guidelines 2018: Microvascular and macrovascular complications in children and adolescents.

Authors:  Kim C Donaghue; M Loredana Marcovecchio; R P Wadwa; Emily Y Chew; Tien Y Wong; Luis Eduardo Calliari; Bedowra Zabeen; Mona A Salem; Maria E Craig
Journal:  Pediatr Diabetes       Date:  2018-10       Impact factor: 4.866

Review 5.  Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy.

Authors:  Yu Zhang; Xinghui Sun; Basak Icli; Mark W Feinberg
Journal:  Endocr Rev       Date:  2017-04-01       Impact factor: 19.871

6.  Inhibition of SNAP25 expression by HIV-1 Tat involves the activity of mir-128a.

Authors:  Davide Eletto; Giuseppe Russo; Giovanni Passiatore; Luis Del Valle; Antonio Giordano; Kamel Khalili; Elisa Gualco; Francesca Peruzzi
Journal:  J Cell Physiol       Date:  2008-09       Impact factor: 6.384

7.  Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy.

Authors:  John Doupis; Thomas E Lyons; Szuhuei Wu; Charalambos Gnardellis; Thanh Dinh; Aristidis Veves
Journal:  J Clin Endocrinol Metab       Date:  2009-03-10       Impact factor: 5.958

8.  MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness.

Authors:  Cristina Evangelisti; Maria Carolina Florian; Isabella Massimi; Carlo Dominici; Giuseppe Giannini; Silvia Galardi; Maria Cristina Buè; Simone Massalini; Heather P McDowell; Elio Messi; Alberto Gulino; Maria Giulia Farace; Silvia Anna Ciafrè
Journal:  FASEB J       Date:  2009-08-27       Impact factor: 5.191

Review 9.  Large fibre, small fibre and autonomic neuropathy in adolescents with type 1 diabetes: A systematic review.

Authors:  Vinni Faber Rasmussen; Troels Staehelin Jensen; Hatice Tankisi; Páll Karlsson; Esben Thyssen Vestergaard; Kurt Kristensen; Jens Randel Nyengaard; Astrid Juhl Terkelsen
Journal:  J Diabetes Complications       Date:  2021-08-18       Impact factor: 2.852

Review 10.  Role of inflammatory biomarkers in diabetic peripheral neuropathy.

Authors:  Heung Yong Jin; Tae Sun Park
Journal:  J Diabetes Investig       Date:  2018-01-22       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.